(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FLUAD QUADRIVALENT INFLUENZA VACCINE, ADJUVANTED

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

FLUAD QUADRIVALENT INFLUENZA VACCINE, ADJUVANTED

ST13

US500000087682651

Class

5

Filing

87682651

Registration

6364692

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

05/26/2026

Trademark type

Combined

Nice classes

5

Filing date

11/13/2017

Registration date

05/25/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/25/2021

Last transaction

05/26/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/04/2021

First use in commerce

03/04/2021

Drawing code

3

Owner type

99

Owner location

Maidenhead, Berkshire, GB

Examiner

MCMORROW, RONALD G

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the term "FLUAD" above the word "QUADRIVALENT" above the words "INFLUENZA VACCINE," above the word "ADJUVANTED". Above the term "FLUAD" are four curved rows of solid blue circles that fade in color from right to left. To the right of these rows of circles are two bigger vertically overlapping circles with the top circle in blue and the bottom circle in green. To the right of these two circles is another set of two vertically overlapping circles with the top circle in green and the bottom circle in blue. The letters "FLU" in the term "FLUAD" and the word "QUADRIVALENT" are in blue. The letters "AD" in the term "FLUAD" and the words "INFLUEZA VACCINE, ADJUVANTED" are in green.

Holders and representatives

Holders

Seqirus UK Limited
Seqirus UK Limited

Representatives

Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Influenza vaccines for human use

Publications

History of USPTO decisions and trademark events.

39 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/25/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/25/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/23/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/22/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/14/2021

IUAF

USE AMENDMENT FILED

04/12/2021

EISU

TEAS STATEMENT OF USE RECEIVED

04/12/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/19/2020

EX5G

SOU EXTENSION 5 GRANTED

09/18/2020

EXT5

SOU EXTENSION 5 FILED

09/16/2020

EEXT

SOU TEAS EXTENSION RECEIVED

09/16/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/05/2020

EX4G

SOU EXTENSION 4 GRANTED

02/03/2020

EXT4

SOU EXTENSION 4 FILED

02/03/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/03/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/11/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/11/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/08/2019

EX3G

SOU EXTENSION 3 GRANTED

10/04/2019

EXT3

SOU EXTENSION 3 FILED

10/04/2019

EEXT

SOU TEAS EXTENSION RECEIVED

10/04/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/13/2019

EX2G

SOU EXTENSION 2 GRANTED

04/12/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/12/2019

EXT2

SOU EXTENSION 2 FILED

04/08/2019

EEXT

SOU TEAS EXTENSION RECEIVED

04/08/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/09/2018

EX1G

SOU EXTENSION 1 GRANTED

10/05/2018

EXT1

SOU EXTENSION 1 FILED

10/05/2018

EEXT

SOU TEAS EXTENSION RECEIVED

10/05/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/10/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/13/2018

PUBO

PUBLISHED FOR OPPOSITION

02/13/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/24/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/04/2018

DOCK

ASSIGNED TO EXAMINER

12/31/2017

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/25/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/24/2017

NWAP

NEW APPLICATION ENTERED

11/16/2017

Continuous trademark protection

Get notified about every new filing that threatens FLUAD QUADRIVALENT INFLUENZA VACCINE, ADJUVANTED or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.